CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
(4,319 of 4,327) of infusions were completed without a reduction, interruption, or discontinuation due to tolerability
Do not use CUVITRU if you1:
What should I avoid while taking CUVITRU?1
See how CUVITRU’s infusion options helped 3 people fit PI treatment into their lives.
1. CUVITRU. Prescribing Information, Takeda Pharmaceuticals USA Inc.; 2023.